SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI)

CUSIP: 09073Q204

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / SPON ADS NEW
Total 13F shares
462,433
Share change
-152,073
Total reported value
$275,246
Price per share
$0.60
Number of holders
11
Value change
-$90,572
Number of buys
4
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 09073Q204?
CUSIP 09073Q204 identifies SCNI - SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI) as of Q4 2023

As of 31 Dec 2023, SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 462,433 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, SABBY MANAGEMENT, LLC, RHUMBLINE ADVISERS, MORGAN STANLEY, UBS Group AG, CREDIT AGRICOLE S A, Main Street Group, LTD, Aspire Private Capital, LLC, Global Retirement Partners, LLC, and WELLS FARGO & COMPANY/MN. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.